ArticleThe Journal of pharmacology and experimental therapeutics2012

P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.

Sarah M Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.